Sectors

Illumina, General Atlantic and Viking Global Investors supplied $70m for Ginkgo Bioworks, a cell programming technology provider that has now raised more than $789m altogether.

Amazon Alexa Fund contributed to the home automation technology producer's series C round through its Alexa Fund, revealing itself as an existing investor in the process.

Existing investors Hewlett Packard Enterprise, GV, Intel Capital, SingTel Innov8 and M12 all participated as the cybersecurity services provider took its total funding to $112m.

Existing backer Ligand took part in a series C round that will fund late-stage clinical trials for Palvella Therapeutics' rare genetic disease drug candidates.

Lactips, a milk-based bioplastics spinout of Jean Monnet University formed by Pulsalys, has raised $14.5m in a funding round led by Bpifrance.

Q32 Bio has launched with $46m from investors including Sanofi Ventures and Children’s Hospital Colorado to target autoimmune and inflammatory diseases.

Atom Bioscience will use the capital from the series B round, which was co-led by Livzon Pharmaceutical, to advance its gout treatment into phase 2 trials.

Fuyo General Lease and Itochu Technology Ventures both invested as the cell-sorting technology developer completed a $15.3m round.

The milk-based bioplastics developer received the funding from investors including Mitsubishi Chemical Holdings' Diamond Edge Ventures subsidiary.

Gene sequencing corporate spinoff MGI Tech closed a $1bn series B round backed by IDG Capital and CPE Capital. The company offers an array of products, some of which have been used for Covid-19 detection and forms part of the promising space of genetics tech.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.